Rosalind Advisors, Inc. Portfolio Stock Holdings
Rosalind Advisors, Inc. disclosed 32 stock positions valued at approximately $244.1 million in its latest SEC 13F filing. The largest holdings include DELCATH SYSTEMS, INC., XERIS BIOPHARMA HOLDINGS INC, and FENNEC PHARMACEUTICALS INC. The filing reflects positions held as of March 31, 2026 and was filed on May 14, 2026.
- Report Period
- March 31, 2026
- No. of Stocks
- 32
- Portfolio Value
- $244.1M
Holdings by Sector
Rosalind Advisors, Inc. Portfolio Holdings in Q1 2026
22 holdings in the latest reporting period.
Page 1 of 1
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| DELCATH SYSTEMS, INC. | DCTH | Healthcare | 12.55% | 3,300,389 | - | - | $30,627,610 |
| XERIS BIOPHARMA HOLDINGS INC | XERS | Healthcare | 7.68% | 3,231,700 | +1,120,000 | +53.04% | $18,743,860 |
| FENNEC PHARMACEUTICALS INC | FENC | Healthcare | 7.33% | 2,908,201 | +294,693 | +11.28% | $17,885,436 |
| SAVARA INC | SVRA | Healthcare | 7.17% | 3,203,721 | -200,000 | -5.88% | $17,492,317 |
| VAXCYTE INC | PCVX | Healthcare | 6.90% | 290,000 | +290,000 | +100.00% | $16,851,900 |
| EYEPOINT PHARMACEUTICALS INC | EYPT | Healthcare | 5.48% | 1,036,737 | +346,737 | +50.25% | $13,363,540 |
| VERASTEM INC | VSTM | Healthcare | 4.64% | 2,138,475 | +350,000 | +19.57% | $11,333,918 |
| CELLDEX THERAPEUTICS INC | CLDX | Healthcare | 4.29% | 330,000 | +330,000 | +100.00% | $10,467,600 |
| BIOCRYST PHARMACEUTICALS INC | BCRX | Healthcare | 3.60% | 923,057 | +923,057 | +100.00% | $8,787,503 |
| CG ONCOLOGY INC | CGON | Healthcare | 2.77% | 100,000 | -200,000 | -66.67% | $6,768,000 |
| INSPIREMD INC | NSPR | Healthcare | 2.61% | 3,905,743 | - | - | $6,366,361 |
| ATEA PHARMACEUTICALS INC | AVIR | Healthcare | 2.58% | 1,171,855 | +1,171,855 | +100.00% | $6,304,580 |
| PROFOUND MEDICAL CORP | PROF | Healthcare | 2.20% | 828,118 | -240,837 | -22.53% | $5,366,205 |
| VIRIDIAN THERAPEUTICS INC | VRDN | Healthcare | 2.01% | 250,401 | -199,599 | -44.36% | $4,897,844 |
| MYOMO INC | MYO | Healthcare | 1.06% | 3,847,272 | +7,500 | +0.20% | $2,599,217 |
| TALPHERA INC | TLPH | Healthcare | 1.03% | 3,353,916 | -225,357 | -6.30% | $2,505,040 |
| OVID THERAPEUTICS INC | OVID | Healthcare | 1.01% | 1,107,994 | +1,107,994 | +100.00% | $2,459,747 |
| LIPOCINE INC | LPCN | Healthcare | 0.73% | 221,616 | +221,616 | +100.00% | $1,770,712 |
| AVALO THERAPEUTICS INC | AVTX | Healthcare | 0.46% | 75,000 | +75,000 | +100.00% | $1,119,750 |
| ANNEXON INC | ANNX | Healthcare | 0.45% | 200,000 | +200,000 | +100.00% | $1,108,000 |
| AQUESTIVE THERAPEUTICS INC | AQST | Healthcare | 0.43% | 250,000 | +250,000 | +100.00% | $1,037,500 |
| KURA ONCOLOGY INC | KURA | Healthcare | 0.33% | 100,000 | - | - | $813,000 |